UBS Portfolio Cuts Signal Strategic Rebalancing Ahead of Q2 Earnings and Integration Finish Line
Published on 07/21/2026 at 17:43 | Redaktion boerse-global.de
UBS has quietly trimmed its exposure to several major holdings in recent days, paring stakes in German chemicals group Lanxess, Hong Kong-listed insurer Ping An, and travel booking platform Web Travel Group. The portfolio adjustments come just as the Swiss banking giant prepares to deliver its second-quarter results on 29 July, a report that will test whether the bank can sustain the momentum from a stellar first quarter.
The most substantial reduction was at Lanxess, where UBS lowered its total voting rights to 6.22% from 6.87%, with directly held shares accounting for 4.4% of the stake. The threshold was crossed on 17 July, according to a regulatory filing. That same day, UBS and affiliated companies fell below the reporting threshold at Web Travel Group, exiting a position as a significant shareholder. Earlier, on 15 July, the bank reduced its long position in Ping An H-shares from 7.39% to 6.83%, as disclosed in a filing to the Hong Kong exchange. The moves form part of a broader series of portfolio rebalancing that UBS has executed across several holdings in recent weeks.
The timing of these reductions is noteworthy. UBS shares recently touched a 52-week high of €48.19 on 16 July, only to pull back in the subsequent sessions. By Monday the stock had closed at €45.13, a 2.17% daily loss and a 4.24% weekly decline, leaving it 6.35% below the high. However, the share price recovered somewhat on Tuesday, trading at €45.62, up 1.09% on the day. Despite the short-term weakness, the stock remains up 14.71% year-to-date in euro terms (13.48% per the secondary source’s figure), and the Relative Strength Index at 53.4 suggests no overheating. Analysts broadly view the retreat as a healthy consolidation rather than a reversal.
Investor attention is now fixed on the upcoming quarterly numbers. The consensus forecast calls for earnings per share of $0.88 on revenue of roughly $13.11bn for the second quarter. That would build on a powerful first quarter, when UBS reported net profit of $3.0bn, an 80% year-on-year surge, and a return on CET1 capital of 16.8%. Global Wealth Management attracted net new money of $37bn in the period. Looking ahead to the full year, analysts project EPS of $3.50 and expect the dividend to be raised to $1.25 per share (the 2025 dividend was set at $1.10 at the April AGM).
Should investors sell immediately? Or is it worth buying UBS?
A key operational milestone was reached in March, when UBS completed the global migration of approximately 1.2 million former Credit Suisse clients onto its own IT systems. The broader integration of its former rival remains on track for completion by the end of 2026, with cumulative cost savings already standing at around $13bn. The completion of the client migration eliminates a major operational risk, clearing the way for management to focus more squarely on revenue generation and capital returns.
Analyst ratings have remained constructive. JPMorgan initiated coverage on 6 July with a price target of CHF 44.00, and RBC Capital Markets reiterated its “Outperform” rating with a CHF 40.00 target on 9 July. The RBC view in particular suggests that the recent share price weakness may offer an entry point ahead of the Q2 print.
In a separate development, UBS is exploring a new financial structure to securitize private credit fund stakes into bonds, targeting an A2 rating from Moody’s backed by a credit guarantee from Nationwide Mutual Insurance. If executed, the deal would expand UBS’s presence in the growing private credit securitization market. Meanwhile, the bank’s “Global Wealth Report 2026” estimated global private wealth grew by 10.8% last year and counted 2.6 million dollar millionaires in Germany alone.
UBS at a turning point? This analysis reveals what investors need to know now.
With all key integration steps largely behind it and a strong first quarter as a springboard, UBS now faces the market’s verdict on whether it can deliver a repeat performance. The 29 July numbers will provide the first concrete answer.
Ad
UBS Stock: New Analysis - 21 July
Fresh UBS information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
